MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$789,612K
Net Income
$148,361K
Net Profit Margin
18.79%
EPS
$1.1
Unit: Thousand (K) dollars
Revenue Breakdown
US
Non Us
Revenue Breakdown
Musculoskeletal Solutions
Enabling Technologies
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net sales
789,612
759,854
826,420
769,048
Cost of sales (exclusive of amortization of intangibles)
241,439
234,066
261,107
252,533
Research and development
36,321
36,510
36,163
38,067
Selling, general and administrative
286,823
297,775
318,480
313,597
Amortization of intangibles
29,560
29,526
29,360
29,843
Acquisition-related costs
11,080
6,377
10,826
-2,713
Restructuring costs
1,957
5,212
1,144
358
Operating income/(loss)
182,432
150,388
169,340
137,363
Interest income/(expense), net
7,074
5,434
2,776*
1,455
Foreign currency transaction gain/(loss)
-860
-2,113
-7,153
-161
Barloss purchase loss
0
1,118
3,879*
3,800
Other income/(expense)
1,171
2,247
391
1,537
Total other income/(expense), net
7,385
6,686
-107
6,631
Income/(loss) before income taxes
189,817
157,074
169,233
143,994
Income tax provision/(benefit)
38,248
32,772
28,639
25,028
Net income/(loss)
151,569
124,302
140,594
118,966
Unrealized gain/(loss) on marketable securities
-551
-1,160
101
30
Foreign currency translation gain/(loss)
-2,657
218
4,318
658
Total other comprehensive income/(loss), net of tax
-3,208
-942
4,419
688
Comprehensive income/(loss)
148,361
123,360
145,013
119,654
Basic EPS
1.12
0.92
1.079
0.88
Diluted EPS
1.1
0.9
1.062
0.88
Basic Average Shares
135,054,000
135,364,000
134,396,000
134,502,000
Diluted Average Shares
137,384,000
138,191,000
136,557,000
135,394,000
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
1
2
US
$619,105K
(3.05%↑ Y/Y)
Non Us
$170,507K
(17.95%↑ Y/Y)
Net sales
$789,612K
(5.94%↑ Y/Y)
Interest
income/(expense), net
$7,074K
(920.78%↑ Y/Y)
Other
income/(expense)
$1,171K
(51.68%↑ Y/Y)
Operating income/(loss)
$182,432K
(139.70%↑ Y/Y)
Total other
income/(expense), net
$7,385K
(-93.41%↓ Y/Y)
Selling, general and
administrative
$286,823K
(-5.53%↓ Y/Y)
Cost of sales
(exclusive of amortization...
$241,439K
(-2.94%↓ Y/Y)
Research and development
$36,321K
(-9.09%↓ Y/Y)
Amortization of intangibles
$29,560K
(-2.08%↓ Y/Y)
Acquisition-related costs
$11,080K
(-66.58%↓ Y/Y)
Restructuring costs
$1,957K
(-85.55%↓ Y/Y)
Foreign currency
transaction gain/(loss)
-$860K
(-2363.16%↓ Y/Y)
Income/(loss) before income
taxes
$189,817K
(0.87%↑ Y/Y)
Net income/(loss)
$151,569K
(-25.28%↓ Y/Y)
Income tax
provision/(benefit)
$38,248K
(360.67%↑ Y/Y)
Comprehensive income/(loss)
$148,361K
(-31.08%↓ Y/Y)
Total other
comprehensive income/(loss),...
-$3,208K
(-125.86%↓ Y/Y)
Foreign currency
translation gain/(loss)
-$2,657K
(-121.42%↓ Y/Y)
Unrealized gain/(loss) on
marketable securities
-$551K
(-27650.00%↓ Y/Y)
Buy us a coffee
GLOBUS MEDICAL INC (GMED)
GLOBUS MEDICAL INC (GMED)